Drugs / TDV New Formulation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01542632 | Feb 2012 → Jan 2014 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDV New Formulation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01542632 ↗ |
| Modality | Vaccine | “dengue vaccine” NCT01542632 ↗ |
| Route | Subcutaneous | “TDV New Formulation subcutaneous injection” NCT01542632 ↗ |